Selection of tumor-specific internalizing human antibodies from phage libraries.
about
Killing cancer cells by targeted drug-carrying phage nanomedicinesIdentification of MCAM/CD146 as the target antigen of a human monoclonal antibody that recognizes both epithelioid and sarcomatoid types of mesotheliomaA simple method for displaying recalcitrant proteins on the surface of bacteriophage lambda.Chemical strategies for the covalent modification of filamentous phageMolecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxinCellular internalization mechanism and intracellular trafficking of filamentous M13 phages displaying a cell-penetrating transbody and TAT peptideEngineering an Anti-Transferrin Receptor ScFv for pH-Sensitive Binding Leads to Increased Intracellular AccumulationHigh-content analysis of antibody phage-display library selection outputs identifies tumor selective macropinocytosis-dependent rapidly internalizing antibodies.Tumor cell-targeting by phage-displayed peptides.Identification using phage display of peptides promoting targeting and internalization into HPV-transformed cell lines.Combinatorial approaches for the identification of brain drug delivery targets.The use of phage display in the study of receptors and their ligands.Production of a human single-chain variable fragment antibody against esophageal carcinomaPhage display selection for cell-specific ligands: development of a screening procedure suitable for small tumor specimens.Identification of clinically significant tumor antigens by selecting phage antibody library on tumor cells in situ using laser capture microdissection.In vivo selection of phage for the optical imaging of PC-3 human prostate carcinoma in mice.A novel assay for monitoring internalization of nanocarrier coupled antibodies.The use of immunoliposome for nutrient target regulation (a review).Mining a yeast library for brain endothelial cell-binding antibodies.Design of synthetic antibody libraries.Identification and characterization of tumor antigens by using antibody phage display and intrabody strategies.Impact of single-chain Fv antibody fragment affinity on nanoparticle targeting of epidermal growth factor receptor-expressing tumor cells.Targeted drug delivery to mesothelioma cells using functionally selected internalizing human single-chain antibodiesIsolation of specific and biologically active peptides that bind cells from patients with acute myeloid leukemia (AML).A yeast display immunoprecipitation method for efficient isolation and characterization of antigens.Human antibodies targeting cell surface antigens overexpressed by the hormone refractory metastatic prostate cancer cells: ICAM-1 is a tumor antigen that mediates prostate cancer cell invasion.Generation of novel single-chain antibodies by phage-display technology to direct imaging agents highly selective to pancreatic beta- or alpha-cells in vivo.Identification of internalizing human single-chain antibodies targeting brain tumor sphere cells.Internalizing cancer antibodies from phage libraries selected on tumor cells and yeast-displayed tumor antigensFusogenics: a recombinant immunotoxin-based screening platform to select internalizing tumor-specific antibody fragments.Identifying blood-brain-barrier selective single-chain antibody fragments.Beyond natural antibodies: the power of in vitro display technologies.Discovery of internalizing antibodies to tumor antigens from phage libraries.A novel in vivo method for isolating antibodies from a phage display library by neuronal retrograde transport selectively yields antibodies against p75(NTR.).Selection and characterization of cell binding and internalizing phage antibodies.High throughput identification of monoclonal antibodies to membrane bound and secreted proteins using yeast and phage display.Identification of inhibitory scFv antibodies targeting fibroblast activation protein utilizing phage display functional screens.Antibody affinity maturation using yeast display with detergent-solubilized membrane proteins as antigen sourcesStreamlining hit discovery and optimization with a yoctoliter scale DNA reactor.Intravenous infusion of phage-displayed antibody library in human cancer patients: enrichment and cancer-specificity of tumor-homing phage-antibodies
P2860
Q21256651-A9F6AADF-0FED-4DC9-BEB7-240D8045EDF7Q24646373-ECDCBF52-115F-4AF4-863B-EEB53A007897Q24813872-B9DB6BE7-DF3B-4EC1-9319-838912C1EA59Q26992196-E5B9739A-0B2C-49DD-9DFC-AEB18C9138D8Q27643327-DA368373-FE12-4A60-8434-D70D0445E6DEQ28484366-DA97FF7A-2CA3-4414-822F-CF8199A0F087Q28551823-811AAB2F-DE4A-4F64-A5D7-D862196B4E87Q30605298-500A6CF6-8C0A-4A4D-BC2F-D48259535F3BQ31087157-5279B8FA-AA40-40B9-8353-2D477A8FAFDDQ31114638-C05441DC-C76E-4F9F-B89B-3C8CDD915825Q31119779-6C811733-FCA3-42B9-9347-07EFC3BFA01CQ31122757-7CB8714A-D368-43E0-9DE9-AA2F5B7E744AQ33205947-3B6D0405-E015-4F0F-A3C8-A0893AD2475AQ33214333-D118D81B-B4F1-4787-A303-20BCE8DA487EQ33257951-7099192E-D137-453A-8F5A-A042FFFEB4A7Q33258073-1D89B4A3-192B-4D83-8427-0EBCA9111FD1Q33259109-E9E43A3C-09BF-45FB-BCF0-30441AAB0359Q33263078-9F7BEAFC-9BE5-4662-97B6-B4B1D05C367CQ33268344-236C16B9-0178-44DB-B240-06B0BE4677E8Q33283622-38EF7BF5-2B62-4354-8359-35DAADC76519Q33284494-242AD6D7-7D1C-4BCE-BFF3-90303834048FQ33289414-C9913A80-80FC-4E37-8A26-1AA6F56A1C31Q33322420-BB8E93CF-E8D4-4A19-B53D-668E8E302802Q33350679-E402CE59-3151-4C6F-8F78-145369F5AC4AQ33388079-43862078-F66D-4088-9224-A394987959FCQ33409529-3F4184AB-32C4-4A1C-889F-253A0EE172E2Q33480823-A12BACE4-6DB0-478D-B687-36ECC91C2CC3Q33620053-2C7FAB25-1FE1-446A-AC5E-A7B72424E879Q33695432-A9193CC0-CFA8-4879-AA9D-1F09B3BE398AQ33763294-28B611AE-B6A2-4076-A834-5C8FA930C578Q33816474-207EE2BA-345B-45E2-8471-D20E5191314AQ33841864-CB738461-F5C5-471E-A414-937AE0BA53E3Q34114794-DBF58156-3C03-4161-9D25-9322449D446EQ34212777-049317E8-FA37-42CE-AEB0-7BDC6282EF6BQ34280931-BE045962-8428-4955-B415-C35C8356EDF8Q34421055-756B9F20-0622-4929-88A5-BD3C8AD7F93BQ34459039-3A231607-8CF7-429D-A452-C48F7B2F1E56Q34460171-8C2B8265-3612-45EE-B4C6-6F710E4697E6Q34616688-4B0B93FF-BDB0-4149-B3F6-60B5383CB85EQ34757809-D8375217-BCCA-4470-82FD-84C6167EBDB2
P2860
Selection of tumor-specific internalizing human antibodies from phage libraries.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Selection of tumor-specific internalizing human antibodies from phage libraries.
@ast
Selection of tumor-specific internalizing human antibodies from phage libraries.
@en
type
label
Selection of tumor-specific internalizing human antibodies from phage libraries.
@ast
Selection of tumor-specific internalizing human antibodies from phage libraries.
@en
prefLabel
Selection of tumor-specific internalizing human antibodies from phage libraries.
@ast
Selection of tumor-specific internalizing human antibodies from phage libraries.
@en
P2093
P356
P1476
Selection of tumor-specific internalizing human antibodies from phage libraries.
@en
P2093
P304
P356
10.1006/JMBI.2000.4026
P407
P577
2000-09-01T00:00:00Z